La catena delle opzioni mostra i dati chiave delle opzioni azionarie di CLS Holdings USA a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per CLS Holdings USA..

CLS Holdings USA (OTC:CLSH) Azioni, Catena delle Opzioni

CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.

CLS HOLDINGS USA INC by CLS Holdings USA, Inc.

CLS Holdings USA Inc

Citigroup analyst Atif Malik maintains Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>) with a Buy and raises the price target from $92 to $97.

News

Price Target

Analyst Ratings

ANET

Citigroup Maintains Buy on Arista Networks, Raises Price Target to $97

Keefe, Bruyette &amp; Woods analyst Ryan Krueger maintains Equitable Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQH#NYSE">EQH</a>) with a Outperform and raises the price target from $61 to $63.

Keefe, Bruyette & Woods Maintains Outperform on Equitable Holdings, Raises Price Target to $63

Keefe, Bruyette &amp; Woods analyst Ryan Krueger maintains Corebridge Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRBG#NYSE">CRBG</a>) with a Outperform and raises the price target from $37 to $39.

CRBG

Keefe, Bruyette & Woods Maintains Outperform on Corebridge Financial, Raises Price Target to $39

Citigroup analyst Tyler Radke maintains ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Buy and raises the price target from $1128 to $1160.

Citigroup Maintains Buy on ServiceNow, Raises Price Target to $1160

Keefe, Bruyette &amp; Woods analyst Damon Delmonte maintains Camden National (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAC#NASDAQ">CAC</a>) with a Market Perform and lowers the price target from $48 to $47.

Keefe, Bruyette & Woods Maintains Market Perform on Camden National, Lowers Price Target to $47

Citigroup analyst Mark Zhang maintains DigitalOcean Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCN#NYSE">DOCN</a>) with a Buy and lowers the price target from $50 to $40.

DOCN

Citigroup Maintains Buy on DigitalOcean Holdings, Lowers Price Target to $40

Wedbush analyst Laura Chico initiates coverage on Jade Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBIO#NASDAQ">JBIO</a>) with a Outperform rating and announces Price Target of $17.

Initiation

JBIO

Wedbush Initiates Coverage On Jade Biosciences with Outperform Rating, Announces Price Target of $17

<a href="https://www.airbus.com/en/products-services/commercial-aircraft/orders-and-deliveries" title="https://www.airbus.com/en/products-services/commercial-aircraft/orders-and-deliveries">https://www.airbus.com/en/products-services/commercial-aircraft/orders-and-deliveries</a>

European Aeronautic Defence And Space Unsponsored

EADSY

Airbus April Deliveries Totaled 56 To 33 Customers; April Gross Orders 11; 2025 Deliveries To Date 192; Booked 291 Gross Aircraft Orders In Jan-April; Booked 215 Net Aircraft Orders In Jan-April; Delivered 13 A350 Aircraft In Jan-April; Delivered 52 A320neo Aircraft In Jan-April; Delivered 92 A321neo Aircraft In Jan-April

Citigroup analyst David Lebowitz maintains Cytokinetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYTK#NASDAQ">CYTK</a>) with a Buy and lowers the price target from $86 to $80.

CYTK

Citigroup Maintains Buy on Cytokinetics, Lowers Price Target to $80

Citigroup analyst Vikram Bagri maintains Shoals Technologies Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHLS#NASDAQ">SHLS</a>) with a Neutral and raises the price target from $4.5 to $5.5.

SHLS

Citigroup Maintains Neutral on Shoals Technologies Gr, Raises Price Target to $5.5

Keefe, Bruyette &amp; Woods analyst Ryan Krueger maintains Ameriprise Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMP#NYSE">AMP</a>) with a Market Perform and raises the price target from $510 to $520.

Keefe, Bruyette & Woods Maintains Market Perform on Ameriprise Finl, Raises Price Target to $520

Icahn Enterprises L.P. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IEP#NASDAQ">IEP</a>) shares were trading lower in the premarket session on Wednesday<a href="https://www.benzinga.com/pressreleases/25/05/n45249885/icahn-enterprises-l-p-nasdaq-iep-today-announced-its-first-quarter-2025-financial-results" target="_blank" rel="noreferrer noopener"> after reporting its first-quarter results.</a>
The company reported earnings per share of 79 cents, a loss that missed the street view of 19 cents. Quarterly sales of $2.002 billion also missed the analyst consensus estimate of $2.628 billion.
Adjusted EBITDA loss was&nbsp;$(287) million&nbsp;for the three months ended&nbsp;March 31, compared to an Adjusted EBITDA of&nbsp;$134 million.
As of March 31, net asset value fell by $336 million from December 31, mainly due to $224 million in healthcare investment losses.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/long-ideas/25/04/44845918/carl-icahn-loads-up-cvr-energy-stock-drops-27-million-on-bullish-april-binge" rel="noreferrer noopener">Carl Icahn Loads Up CVR Energy Stock, Drops $27 Million On Bullish April Binge</a>
On May 5, the board of directors of Icahn Enterprises&#8217; general partner declared a quarterly distribution of $0.50 per depositary unit, which will be paid on or about June 25.
The company exited the quarter with cash and equivalents worth $2.183 billion and inventories worth one billion dollars.
Icahn Enterprises reported a net loss from investment activities worth $(394) million, compared with $(96) million in the year-ago period.
Petroleum&#8217;s first-quarter results were hurt by downtime from the Coffeyville refinery turnaround, which was completed in April 2025. During the quarter, the company processed about 120,000 barrels per day.
Price Action: IEP shares were trading lower by 1.89% to $8.560 at last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/05/45252150/novo-nordisk-expects-fda-decision-for-oral-wegovy-by-end-of-2025-reports-mixed-q1-earnings" target="_blank" rel="noreferrer noopener">Novo Nordisk&#8217;s Wegovy Sales Surge 85% But Compounded Weight Loss Drugs In US Impacts Annual Outlook</a></li>
</ul>
Photo: Shutterstock

Equities

Markets

Movers

General

What's Going On With Icahn Enterprises Stock Today?

Keybanc analyst Ashley Owens maintains Revolve Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RVLV#NYSE">RVLV</a>) with a Overweight and lowers the price target from $37 to $25.

RVLV

Keybanc Maintains Overweight on Revolve Gr, Lowers Price Target to $25

Williams-Sonoma (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WSM#NYSE">WSM</a>) has outperformed the market over the past 15 years by 6.15% on an annualized basis producing an average annual return of 17.21%. Currently, Williams-Sonoma has a market capitalization of $19.07 billion. 
Buying $1000 In WSM: If an investor had bought $1000 of WSM stock 15 years ago, it would be worth $10,270.89 today based on a price of $154.41 for WSM at the time of writing.
<h3>Williams-Sonoma's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746632713_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In Williams-Sonoma 15 Years Ago Would Be Worth This Much Today

Keefe, Bruyette &amp; Woods analyst Meyer Shields maintains Allstate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALL#NYSE">ALL</a>) with a Outperform and raises the price target from $228 to $235.

Keefe, Bruyette & Woods Maintains Outperform on Allstate, Raises Price Target to $235

Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) will release earnings results for the third quarter, after the <a href="https://www.benzinga.com/quote/arm/earnings">closing bell on Wednesday, May 7.</a>
Analysts expect the Cambridge, the UK-based company to report quarterly earnings at 52 cents per share, up from 36 cents per share in the year-ago period. Arm Holdings projects to report quarterly revenue at $1.23 billion, compared to $928 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On April 16, Cadence announced plans to acquire Arm Artisan Foundation IP business.
Arm Holdings shares rose 0.4% to close at $122.44 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/ARM/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>UBS analyst Timothy Arcuri maintained a Buy rating and cut the price target from $215 to $165 on April 29, 2025. This analyst has an accuracy rate of 75%.</li>
<li>Barclays analyst Blayne Curtis maintained an Overweight rating and slashed the price target from $155 to $125 on April 22, 2025. This analyst has an accuracy rate of 70%.</li>
<li>B of A Securities analyst Vivek Arya maintained a Buy rating and slashed the price target from $180 to $144 on April 16, 2025. This analyst has an accuracy rate of 80%.</li>
<li>Loop Capital analyst Ananda Baruah maintained a Buy rating and increased the price target from $180 to $195 on Feb. 10, 2025. This analyst has an accuracy rate of 70%.</li>
<li>Raymond James analyst Srini Pajjuri maintained an Outperform rating and boosted the price target from $160 to $175 on Feb. 6, 2025. This analyst has an accuracy rate of 79%.</li>
</ul>
Considering buying ARM stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="592" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07033801/image-63-1024x592.png" alt="" class="wp-image-904968" style="width:505px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07033801/image-63-1024x592.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07033801/image-63-300x173.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07033801/image-63-768x444.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/07033801/image-63.png 1112w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/05/45219636/top-2-energy-stocks-that-are-ticking-portfolio-bombs">Top 2 Energy Stocks That Are Ticking Portfolio Bombs</a> </li>
</ul>
Photo via Shutterstock

Earnings

Arm Holdings Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

WIIM

NCEW

NCEW stock has given up its prior gain. New Century Logistics shares were trading higher after signing a memorandum of understanding with Soradynamics to develop and deploy an in-vehicle drone logistics system.

Keybanc analyst Sangita Jain maintains Primoris Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRIM#NYSE">PRIM</a>) with a Overweight and raises the price target from $67 to $74.

PRIM

Keybanc Maintains Overweight on Primoris Services, Raises Price Target to $74

Keefe, Bruyette &amp; Woods analyst Ryan Krueger maintains Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) with a Market Perform and raises the price target from $104 to $106.

Keefe, Bruyette & Woods Maintains Market Perform on Aflac, Raises Price Target to $106

Citigroup analyst Asiya Merchant maintains Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) with a Neutral and lowers the price target from $39 to $37.

Comments

CLS Holdings USA

CLS Holdings USA (CLSH) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO